(Amgen, Inc.) Amgen today announced the results of a national Harris Interactive Inc. survey indicating that the vast majority of oncologists and infectious disease specialists are highly concerned about the negative impact infection may have on treatment outcomes in chemotherapy patients, as well as emerging antibiotic resistance.
Post new comment